FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular to the use of the formoterol β2-adrenergic receptor agonist as a solution to reduce the degree of stress-induced damage to the heart.
EFFECT: implementation of the invention makes it possible to expand the arsenal of means that increase the resistance of the heart to stress damage.
1 cl, 1 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF NORMALISATION OF DISTURBANCES IN COAGULATION LINK OF HEMOSTASIS SYSTEM IN EXPERIMENT | 2009 |
|
RU2391713C1 |
| METHOD OF DECREASING BLOOD CATECHOLAMINE CONCENTRATION IN STRESS CONDITIONS | 2008 |
|
RU2396993C2 |
| PHARMACOLOGICALLY ACTIVE SUBSTANCE OF ORGANISM-PROTECTION MATERIAL, METHOD OF PREPARATION THEREOF, AND THERAPEUTIC APPLICATION | 1990 |
|
RU2104704C1 |
| METHOD FOR MODELING ACUTE EMOTIONAL IMMOBILIZATION STRESS IN EXPERIMENT | 2018 |
|
RU2701218C1 |
| METHOD OF REDUCTION OF INCREASED FUNCTIONAL ACTIVITY IN ADRENAL GLAND CORTEX FOR EXPERIMENT IN VIVO | 2007 |
|
RU2349353C2 |
| METHOD OF CORRECTING DISTURBED FUNCTIONAL ACTIVITY OF GLYCOPROTEIN RECEPTORS OF ERYTHROCYTES | 2009 |
|
RU2394611C1 |
| USING DELTA SLEEP INDUCING PEPTIDE FOR HEPATOPROTECTIVE EFFECT IN CHRONIC IMMOBILISATION STRESS | 2013 |
|
RU2538686C1 |
| METHOD FOR SIMULATING CHRONIC EMOTIONAL AND INFORMATION STRESS IN EXPERIMENT | 2018 |
|
RU2697655C1 |
| AGENT FOR DISEASES ASSOCIATED WITH STRESS-RELATED CONDITIONS IN DISEASES AND DISORDERS IN HUMAN AND ANIMALS, AND ALSO METHOD OF TREATING AND/OR PREVENTING WITH USING SUCH AGENT | 2009 |
|
RU2450823C2 |
| METHOD OF REDUCING INCREASE ENDOTHELIN I PRODUCTION IN CONDITIONS OF STRESS | 2009 |
|
RU2394612C1 |
